Literature DB >> 17955353

Cholesterol fill-in model: mechanism for substrate recognition by ABC proteins.

Yasuhisa Kimura1, Atsushi Kodan, Michinori Matsuo, Kazumitsu Ueda.   

Abstract

Many of the 48 or 49 human ABC proteins are involved in lipid homeostasis and in defence against hydrophobic substances in food and the environment. Defects in their functions cause various diseases, suggesting that they play very important roles in human health; however, the mechanism of how they handle enormous numbers of hydrophobic compounds with various structures and molecular weights, or phospholipids and cholesterol, major components of cellular membranes, is not known. We compared the functions of drug-transporting and lipid-transporting ABC proteins, and found that (1) ABC proteins, either lipid or drug transporters, have a similar substrate binding site which recognizes PL and cholesterol, or drugs and cholesterol; (2) Cholesterol in membranes binds to various ABC proteins together with PL or drugs, and plays an important role in substrate recognition, especially by ABCB1/MDR1, where cholesterol fills the empty space in the substrate binding site when small drugs bind to it. ABC proteins exert very flexible substrate recognition, i.e., one-to-many interaction rather than the conventional rigid one-to-one interaction. We propose calling the mechanism the "cholesterol fill-in model".

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17955353     DOI: 10.1007/s10863-007-9109-7

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  28 in total

1.  The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease.

Authors:  M Bodzioch; E Orsó; J Klucken; T Langmann; A Böttcher; W Diederich; W Drobnik; S Barlage; C Büchler; M Porsch-Ozcürümez; W E Kaminski; H W Hahmann; K Oette; G Rothe; C Aslanidis; K J Lackner; G Schmitz
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

2.  Alteration of substrate specificity by mutations at the His61 position in predicted transmembrane domain 1 of human MDR1/P-glycoprotein.

Authors:  Y Taguchi; K Kino; M Morishima; T Komano; S E Kane; K Ueda
Journal:  Biochemistry       Date:  1997-07-22       Impact factor: 3.162

3.  ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein.

Authors:  N Wang; D L Silver; C Thiele; A R Tall
Journal:  J Biol Chem       Date:  2001-04-17       Impact factor: 5.157

4.  Sequence of mdr3 cDNA encoding a human P-glycoprotein.

Authors:  A M van der Bliek; P M Kooiman; C Schneider; P Borst
Journal:  Gene       Date:  1988-11-30       Impact factor: 3.688

5.  Purification and ATPase activity of human ABCA1.

Authors:  Kei Takahashi; Yasuhisa Kimura; Noriyuki Kioka; Michinori Matsuo; Kazumitsu Ueda
Journal:  J Biol Chem       Date:  2006-02-24       Impact factor: 5.157

6.  Enhanced apoA-I-dependent cholesterol efflux by ABCA1 from sphingomyelin-deficient Chinese hamster ovary cells.

Authors:  Kohjiro Nagao; Kei Takahashi; Kentaro Hanada; Noriyuki Kioka; Michinori Matsuo; Kazumitsu Ueda
Journal:  J Biol Chem       Date:  2007-04-03       Impact factor: 5.157

7.  MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping.

Authors:  A J Smith; A van Helvoort; G van Meer; K Szabo; E Welker; G Szakacs; A Varadi; B Sarkadi; P Borst
Journal:  J Biol Chem       Date:  2000-08-04       Impact factor: 5.157

8.  A two-step mechanism for free cholesterol and phospholipid efflux from human vascular cells to apolipoprotein A-1.

Authors:  P E Fielding; K Nagao; H Hakamata; G Chimini; C J Fielding
Journal:  Biochemistry       Date:  2000-11-21       Impact factor: 3.162

9.  Increased lipid rafts and accelerated lipopolysaccharide-induced tumor necrosis factor-alpha secretion in Abca1-deficient macrophages.

Authors:  Masahiro Koseki; Ken-Ichi Hirano; Daisaku Masuda; Chiaki Ikegami; Masaki Tanaka; Akemi Ota; Jose C Sandoval; Yumiko Nakagawa-Toyama; Satoshi B Sato; Toshihide Kobayashi; Yukiko Shimada; Yoshiko Ohno-Iwashita; Fumihiko Matsuura; Iichiro Shimomura; Shizuya Yamashita
Journal:  J Lipid Res       Date:  2006-11-01       Impact factor: 5.922

10.  Naturally occurring mutations in the largest extracellular loops of ABCA1 can disrupt its direct interaction with apolipoprotein A-I.

Authors:  Michael L Fitzgerald; Andrea L Morris; Jeongmi S Rhee; Lorna P Andersson; Armando J Mendez; Mason W Freeman
Journal:  J Biol Chem       Date:  2002-06-25       Impact factor: 5.157

View more
  4 in total

1.  Regulation of the function of the human ABCG2 multidrug transporter by cholesterol and bile acids: effects of mutations in potential substrate and steroid binding sites.

Authors:  Ágnes Telbisz; Csilla Hegedüs; András Váradi; Balázs Sarkadi; Csilla Özvegy-Laczka
Journal:  Drug Metab Dispos       Date:  2014-01-02       Impact factor: 3.922

2.  Multidrug resistance P-glycoprotein dampens SR-BI cholesteryl ester uptake from high density lipoproteins in human leukemia cells.

Authors:  Stefano Spolitu; Sabrina Uda; Stefania Deligia; Alessandra Frau; Maria Collu; Fabrizio Angius; Barbara Batetta
Journal:  Am J Cancer Res       Date:  2016-02-15       Impact factor: 6.166

3.  The ABC transporter MsbA interacts with lipid A and amphipathic drugs at different sites.

Authors:  Alena Siarheyeva; Frances J Sharom
Journal:  Biochem J       Date:  2009-04-15       Impact factor: 3.857

4.  Plant Lessons: Exploring ABCB Functionality Through Structural Modeling.

Authors:  Aurélien Bailly; Haibing Yang; Enrico Martinoia; Markus Geisler; Angus S Murphy
Journal:  Front Plant Sci       Date:  2012-01-05       Impact factor: 5.753

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.